Immunovia AB (publ) Special Call Transcript
()-
Hello, and welcome to our webcast. I'm Jeff Borcherding, the CEO of Immunovia. I'm very excited to be with you today and have a few distinguished panelists to talk with us about the adoption of the IMMray PanCan-d test in the U.S. market.
This has been an exciting time for us as we have finally moved out of the world of R&D and development and into the market. And today, we are joined by some panelists who can help us understand that market -- help us understand the way that the IMMray PanCan-d test may fit and the way that we can all expect to see IMMray used in order to help detect pancreatic cancer early and really improve survival rates.
I'm joined today by David Bakelman, who is the CEO of The National Pancreas Foundation; as well as 2 distinguished clinicians, Dr. Rosario Ligresti, who is a professor of surgery -- I'm sorry, is a professor and the chief of gastroenterology at Hackensack Meridian Medical Center; as well as Dr. Cheryl Meguid, who is a doctor out of nursing practice at the
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
